3177 results for «335»
3177 results
TAVI in complex scenarios - Bicuspid aortic valve disease - putting it all together
20 Nov 2023 – From PCR London Valves 2023
After an overview of what is currently known about TAVI in bicuspid aortic valves, follow the analysis of a real-life clinical case, and get tips on how to perform TAVI in a bicuspid aortic valve in 3 different ways: with a self-expanding supra-annular valve, using a...
Mitral valve intervention in complex scenarios - Valve-in-valve, valve-in-ring, valve-in-MAC
21 Nov 2023 – From PCR London Valves 2023
What role does imaging play in complex mitral interventions such as valve-in-valve, valve-in-ring or valve-in-MAC? Study how CT-scan, fusion imaging, TEE and TOE are used throughout the procedures and analyse the latest trial results on the subject to get an idea.
Transcatheter mitral valve replacement - The wait will be worth it
20 Nov 2023 – From PCR London Valves 2023
Reflect on the past decade of Transcatheter Mitral Valve Replacement (TMVR) to uncover technical and clinical challenges and the lessons they've taught. Explore innovative technologies addressing persistent issues, offering solutions and anticipated timelines. Additionally, delve into the present and future trial designs, exploring the evidence required for...
Lifetime management for the valve patient
20 Nov 2023 – From PCR London Valves 2023
This session focuses on acquiring the necessary knowledge for engaging in discussions with patients about the lifelong management of valve disease. It emphasizes understanding the relevance of life expectancy and comorbidities, as well as providing key information to support shared decision-making between healthcare professionals and patients.
Mitral edge-to-edge repair using advanced imaging techniques
20 Nov 2023 – From PCR London Valves 2023
Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach
20 Nov 2023 – From PCR London Valves 2023
This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...
Rapid-fire - Challenging TAVI procedures - Part 5
21 Nov 2023 – From PCR London Valves 2023
Discover challenging TAVI scenarios in this session: experience the challenges posed by a small annulus with anomalous coronary arteries, delve into the Mitroflow Valve-in-Valve TAVR procedure, witness a unique approach to TAVI in a patient with a mechanical mitral valve, and more!
Rapid-fire - Nightmares in the cathlab - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...
Challenges in TAVIs, are there guideline recommendations?
20 Nov 2023 – From PCR London Valves 2023
The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...
Navigating the crossroads of care: challenges in shared decision-making for doctors and patients
20 Nov 2023 – From PCR London Valves 2023
Tune in to understand the significance of shared decision-making, explore its importance, identify potential barriers, recognize the pivotal role of patient perspectives and engagement, and discover strategies to facilitate its successful integration on both local and global scales.
Top Innovations
20 Nov 2023 – From PCR London Valves 2023
Discover the future of cardiac care with these 3 top innovations! ARTERY, revolutionizing structural heart treatment, Vesalius Transfemoral DMR Repair, combining chordal and annular support in one-transfemoral device, and Approxima, a right ventricular reshaping device, offering a fresh perspective on tricuspid regurgitation.
Legal notice
19 Oct 2018
Updated - August 22nd, 2023
AsiaPCR 2018: General Terms and conditions of sale
MASTER-DAPT: “the MASTER of high-bleeding risk trials”
28 Aug 2021
Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.
Author
Europa Group's General Terms and Conditions of Sale
12 Apr 2024
Ref 02P - Updated June 2024
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
